CME Group (NASDAQ:CME) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

CME Group (NASDAQ:CME) had its price target increased by analysts at Deutsche Bank Aktiengesellschaft from $312.00 to $316.00 in a note issued to investors on Thursday,MarketScreener reports. The firm presently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential upside of 4.54% from the stock’s previous close.

A number of other brokerages have also weighed in on CME. Barclays raised their price objective on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday. Bank of America increased their price target on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. JPMorgan Chase & Co. lifted their price objective on CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research note on Thursday. The Goldman Sachs Group lowered their target price on CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a research report on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods raised their target price on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $297.47.

CME Group Trading Up 1.6%

CME Group stock opened at $302.27 on Thursday. CME Group has a 1 year low of $239.70 and a 1 year high of $302.79. The firm’s 50 day moving average price is $276.90 and its 200-day moving average price is $273.03. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. The stock has a market cap of $109.00 billion, a P/E ratio of 27.09, a PEG ratio of 3.35 and a beta of 0.27.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. CME Group’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.52 earnings per share. On average, equities analysts predict that CME Group will post 10.49 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard purchased 251 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director owned 258,710 shares in the company, valued at $72,017,102.70. This trade represents a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

Large investors have recently made changes to their positions in the stock. Norges Bank bought a new stake in CME Group during the 2nd quarter valued at about $1,571,447,000. Sanders Capital LLC purchased a new position in shares of CME Group during the third quarter worth approximately $1,006,932,000. Strive Asset Management LLC purchased a new position in shares of CME Group during the third quarter worth approximately $636,487,000. Mawer Investment Management Ltd. raised its stake in shares of CME Group by 107.2% during the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after acquiring an additional 777,571 shares in the last quarter. Finally, Viking Global Investors LP purchased a new stake in shares of CME Group in the second quarter valued at approximately $164,648,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 earnings beat and commentary reinforced the firm’s resilient fee-based franchise — investors reacted to better-than-expected quarterly results and the company hitting a new one-year high after the report. Earnings Call Transcript
• Positive Sentiment: Deutsche Bank raised its price target to $316 and maintained a buy rating, giving fresh analyst support that can help momentum. Deutsche Bank PT Raise
• Positive Sentiment: Morgan Stanley reiterated a Buy rating, highlighting CME’s defensive, fee-based franchise and structural growth drivers. Morgan Stanley Note
• Neutral Sentiment: RBC nudged its target to $302 (sector perform) — a small technical change that largely preserves prior sentiment. RBC PT Adjustment
• Positive Sentiment: Management confirmed the firm is exploring a CME-issued digital token and tokenized cash pilots (including work with Google), a strategic move that could expand 24/7 crypto/product offerings and new non-trading revenue streams. CME Token Exploration
• Negative Sentiment: CME raised initial and maintenance margins for gold and silver futures (e.g., gold margins to 9% from 8%, silver to 18% from 15%) to manage sharp volatility — measures that can damp trading volume and futures activity in the near term. Margin Hikes
• Negative Sentiment: Pelican Bay Capital reported selling CME in Q4, signaling at least some institutional trimming that could weigh on sentiment if others follow. Institutional Selling
• Negative Sentiment: JPMorgan still carries an underweight rating despite updating its target — a reminder there are pockets of skepticism about valuation and upside. JPMorgan Note

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.